MI Tumor Seek is a molecular profiling service used to guide the management of advanced cancer
MI Tumor Seek is a molecular profiling service used to guide the management of advanced cancer
CamPROBE may save vital time and money while reducing the risk of infection
ProteoNic’s protein expression technology improves recombinant protein production
A final decision for daprodustat by the FDA is expected by 1 February 2023
Information from 17 existing studies was reviewed, involving 91 million people
TB deaths increase for second year in a row and cases rise for the first time in 20 years
PhoreMost to deploy its Siteseeker protein platform to enable drug discovery
UK only places 11th in terms of total R&D investment as a percentage of GDP
Study involves patients with advanced common cancers and solid tumours
The annual awards recognise the efforts of NHS teams and individuals
The International AIDS Vaccine Initiative is a global nonprofit scientific research organisation
Millions will be invited to join the programme to ‘prevent, detect and treat’ diseases
A series of virtual hackathons are open for innovators to create a technology-based dementia tool
The launch of the laser is part of the NHS’s Long Term Plan commitment
The research could help determine drug responses through genetic testing